Evolutionary Tree Capital Management, LLC

SEC CIK: 0001844345
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ASND holding history

Ascendis Pharma A/S in every 13F filed by Evolutionary Tree Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overview All 13F holders of ASND Full Q2 2026 holdings

Shares (Q2 2026): 6,049
Value: $1.61M
% of portfolio: 3.0%
Quarters held: 22; Since Q1 2021

Holdings of ASND by Evolutionary Tree Capital Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	6,049	$1.61M	3.0%	−3,021−33.3%	Reduced	Holders
Q1 2026	9,070	$2.07M	3.9%	−3,211−26.1%	Reduced	Holders
Q4 2025	12,281	$2.62M	3.0%	−3,062−20.0%	Reduced	Holders
Q3 2025	15,343	$3.05M	3.3%	−3,111−16.9%	Reduced	Holders
Q2 2025	18,454	$3.19M	3.4%	−2,202−10.7%	Reduced	Holders
Q1 2025	20,656	$3.22M	3.7%	−9,459−31.4%	Reduced	Holders
Q4 2024	30,115	$4.15M	4.2%	−2,638−8.1%	Reduced	Holders
Q3 2024	32,753	$4.89M	4.9%	+7,891+31.7%	Added	Holders
Q2 2024	24,862	$3.39M	3.5%	+11,223+82.3%	Added	Holders
Q1 2024	13,639	$2.06M	2.1%	−3,087−18.5%	Reduced	Holders
Q4 2023	16,726	$2.11M	2.3%	+69+0.4%	Added	Holders
Q3 2023	16,657	$1.56M	2.0%	−290−1.7%	Reduced	Holders
Q2 2023	16,947	$1.51M	1.8%	+6,295+59.1%	Added	Holders
Q1 2023	10,652	$1.14M	1.6%	−11,695−52.3%	Reduced	Holders
Q4 2022	22,347	$2.73M	2.6%	−6,799−23.3%	Reduced	Holders
Q3 2022	29,146	$3.01M	2.9%	+6,487+28.6%	Added	Holders
Q2 2022	22,659	$2.11M	2.3%	−14,842−39.6%	Reduced	Holders
Q1 2022	37,501	$4.40M	3.1%	−5,211−12.2%	Reduced	Holders
Q4 2021	42,712	$5.75M	2.8%	+19,470+83.8%	Added	Holders
Q3 2021	23,242	$3.71M	1.6%	+5,872+33.8%	Added	Holders
Q2 2021	17,370	$2.29M	1.1%	+606+3.6%	Added	Holders
Q1 2021	16,764	$2.16M	1.3%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.